首頁 > 市場調查報告書 > 醫療設備

體外診斷

市場調查報告書

商品編碼

1964467

體外診斷免疫診斷材料市場規模、佔有率和成長分析：按產品類型、應用和地區分類－2026-2033年產業預測

IVD Immunodiagnostic Raw Material Market Size, Share, and Growth Analysis, By Product Type (Core Reaction System, Signal System), By Application (Therapeutic Drug Monitoring, Oncology), By Region - Industry Forecast 2026-2033

出版日期: 2026年02月17日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2024年全球體外診斷免疫診斷原料市值為132.3億美元，預計將從2025年的144.6億美元成長到2033年的294.5億美元。預測期（2026-2033年）的複合年成長率預計為9.3%。

體外診斷（IVD）免疫診斷原料市場的主要驅動力是臨床、公共衛生和研究領域對可靠且擴充性的免疫檢測試劑的需求不斷成長。供應商致力於提供各種必要的組件，包括抗體、重組抗原、酵素以及用於檢測感染疾病、腫瘤標記和自體免疫疾病的耗材。單株抗體生產和生物製造技術的進步顯著推動了市場發展，提高了側向流動檢測和實驗室檢測的成本效益。此外，設計和製造流程的技術創新正在加速醫院和診所篩檢計畫的推廣應用。人工智慧透過測試自動化和預測建模增強了品管，從而確保試劑品質和測試性能的一致性。

全球體外診斷免疫診斷原料市場促進因素

全球體外診斷（IVD）免疫診斷原料市場的發展主要受免疫檢測在包括臨床檢查室、醫院和分散式檢查環境在內的各種醫療機構中日益廣泛的應用所驅動。這一趨勢導致對高品質原料（如抗體、抗原、偶聯物和特殊緩衝液）的持續需求。為提高檢測靈敏度和重複性，製造商需要可靠的原料來源和標準化的生產流程。因此，供應商被迫提高產能、加強品管措施並投資於定製配方。這種持續的採購活動為供應商提供了穩定的收入來源，促進了創新，並推動了新檢測方法的推出。最終，這將透過強大的供應鏈和產業內的夥伴關係來推動市場成長。

全球體外診斷免疫診斷原料市場限制因素

全球體外診斷（IVD）免疫診斷原料市場面臨許多限制因素，主要源自於原料監管要求的複雜性和不斷變化。這些嚴格的法規會延長研發週期，並增加供應商和製造商的合規成本，從而阻礙市場成長。對完整文件、批次可追溯性和必要認證的要求，需要投入大量資源用於驗證、品管和法規遵從，這對於尋求進入或拓展市場的中小型供應商而言尤其不利。此外，遵守區域性標準以及持續的上市後監測也會降低營運柔軟性，並延遲產品上市。因此，製造商往往優先考慮現有供應商而非創新新參與企業，阻礙了市場動態。

體外診斷免疫診斷原料的全球市場趨勢

全球體外診斷（IVD）免疫診斷原料市場正經歷著向就地檢驗解決方案的顯著轉變，製造商正專注於專為分散式檢查環境設計的原料。這一趨勢的特點是，對室溫穩定配方、簡化試劑混合物以及與卡盒式系統相容的組件的需求不斷成長。供應商正努力提升產能，並與儀器製造商合作，確保工作流程的無縫銜接和產品品質的穩定性。此外，對小型化和冗餘性的關注也增加了對能夠實現小批量、高特異性檢測的材料的需求。這推動了整個供應鏈的合作日益加強，可靠性、可自訂性和物流柔軟性對於滿足各種照護現場應用不斷變化的需求至關重要。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 墨西哥
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場公司採取的策略
近期市場趨勢
企業市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 按細分市場進行企業市佔率分析
- 2023-2025年營收年比比較

主要企業簡介

Abbott Laboratories
Siemens Healthineers
Roche Diagnostics
Bio-Rad Laboratories
Beckman Coulter
Thermo Fisher Scientific
Quidel Corporation
Agilent Technologies
Meridian Bioscience
Hologic
Ortho Clinical Diagnostics
Genentech
PerkinElmer
Becton, Dickinson and Company
Enzo Biochem
DiaSorin
Fujifilm Wako Pure Chemical Corporation
R-Biopharm AG
Scienion AG
The Binding Site Group

結論與建議

簡介目錄

Product Code: SQMIG35J2192

Global Ivd Immunodiagnostic Raw Material Market size was valued at USD 13.23 Billion in 2024 and is poised to grow from USD 14.46 Billion in 2025 to USD 29.45 Billion by 2033, growing at a CAGR of 9.3% during the forecast period (2026-2033).

The IVD immunodiagnostic raw material market is primarily driven by an increasing need for dependable and scalable reagents essential for immunoassays utilized in clinical, public health, and research environments. Suppliers are focused on delivering a range of necessary components such as antibodies, recombinant antigens, enzymes, and consumables, crucial for testing infectious diseases, oncology biomarkers, and autoimmune disorders. The market has evolved significantly through advancements in monoclonal antibody production and biomanufacturing, enhancing the affordability of lateral flow and lab-based assays. Furthermore, technological innovations in design and manufacturing processes are fostering broader adoption of screening programs in hospitals and clinics. Additionally, AI is augmenting quality control by automating inspections and predictive modeling, thereby ensuring robust reagent quality and assay performance consistency.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Ivd Immunodiagnostic Raw Material market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Ivd Immunodiagnostic Raw Material Market Segments Analysis

Global ivd immunodiagnostic raw material market is segmented by product type, application and region. Based on product type, the market is segmented into Core Reaction System, Signal System, Carrier and Reaction Environment. Based on application, the market is segmented into Therapeutic Drug Monitoring, Oncology, Cardiology, Endocrinology, Infectious Disease Test, Autoimmune Disease and Other. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Ivd Immunodiagnostic Raw Material Market

The global IVD immunodiagnostic raw material market is driven by the rising use of immunoassays in various healthcare settings, including clinical laboratories, hospitals, and decentralized testing environments. This trend has led to a consistent demand for high-quality raw materials such as antibodies, antigens, conjugates, and specialized buffers. Manufacturers, aiming to enhance assay sensitivity and reproducibility, seek dependable sources of materials and standardized manufacturing processes. Consequently, suppliers are compelled to boost their production capacity, enhance quality control measures, and invest in custom formulations. This ongoing procurement supports stable supplier revenues, encourages innovation, and facilitates the introduction of new assays, ultimately fostering market growth through robust supply chains and collaborative industry partnerships.

Restraints in the Global Ivd Immunodiagnostic Raw Material Market

The Global IVD Immunodiagnostic Raw Material market faces significant constraints due to complex and ever-changing regulatory requirements surrounding raw materials. These stringent regulations can hinder market growth by lengthening development timelines and increasing compliance costs for both suppliers and manufacturers. The demands for thorough documentation, batch traceability, and necessary certifications necessitate the allocation of substantial resources toward validation, quality management, and regulatory affairs, which can particularly disadvantage smaller suppliers trying to enter or expand within the market. Furthermore, the need to adhere to varying regional standards and to conduct continuous postmarket surveillance diminishes operational flexibility, delays product launches, and frequently prompts manufacturers to favor established suppliers over innovative newcomers, ultimately stifling market dynamism.

Market Trends of the Global Ivd Immunodiagnostic Raw Material Market

The Global IVD Immunodiagnostic Raw Material market is experiencing a significant shift toward point-of-care testing solutions, prompting manufacturers to focus on raw materials specifically designed for decentralized testing environments. This trend is characterized by a rising demand for room-temperature-stable formulations, simplified reagent mixes, and components compatible with cartridge-based systems. Suppliers are responding by enhancing their production capabilities and engaging in collaborative development with device manufacturers to ensure seamless workflow integration and consistent product quality. Additionally, the emphasis on miniaturization and multiplexing is driving the need for materials that enable low-volume, high-specificity assays, thereby fostering greater collaboration across supply chains and emphasizing reliability, customization, and logistical flexibility to meet the evolving needs of diverse point-of-care applications.

Introduction

Objectives of the Study
Market Definition & Scope

Research Methodology

Research Process
Secondary & Primary Data Methods
Market Size Estimation Methods

Executive Summary

Global Market Outlook
Key Market Highlights
Segmental Overview
Competition Overview

Market Dynamics & Outlook

Macro-Economic Indicators
Drivers & Opportunities
Restraints & Challenges
Supply Side Trends
Demand Side Trends
Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factors
Market Impacting Factors
Top Investment Pockets
Ecosystem Mapping
Market Attractiveness Index 2025
PESTEL Analysis
Regulatory Landscape
Value Chain Analysis

Global IVD Immunodiagnostic Raw Material Market Size by Product Type & CAGR (2026-2033)

Market Overview
Core Reaction System
Signal System
Carrier
Reaction Environment

Global IVD Immunodiagnostic Raw Material Market Size by Application & CAGR (2026-2033)

Market Overview
Therapeutic Drug Monitoring
Oncology
Cardiology
Endocrinology
Infectious Disease Test
Autoimmune Disease
Other

Global IVD Immunodiagnostic Raw Material Market Size & CAGR (2026-2033)

North America (Product Type, Application)
- US
- Canada
Europe (Product Type, Application)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product Type, Application)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product Type, Application)
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa (Product Type, Application)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Abbott Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Roche Diagnostics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Beckman Coulter
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Quidel Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Meridian Bioscience
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hologic
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ortho Clinical Diagnostics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Genentech
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PerkinElmer
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Enzo Biochem
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
DiaSorin
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fujifilm Wako Pure Chemical Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
R-Biopharm AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Scienion AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
The Binding Site Group
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments